ArticleBMC oral health2026
The role of transient receptor potential ankyrin 1 in pyroptosis during pulpitis development.
Article in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundVital pulp therapy has been a widely adopted for managing pulp diseases, in which the control of pulpitis progression is critical. Although the transient receptor potential ankyrin 1 (TRPA1) channel mediates pain transduction and inflammatory responses, its specific role in pyroptosis during pulpitis remains poorly understood.
methodsPulp inflammation was evaluated using H&E staining for group stratification. The expression and localization of TRPA1 and pyroptosis-related markers (NLRP3, cleaved caspase-1, and IL-1β) were assessed by immunohistochemistry. Additionally, qRT‒PCR and Western blotting were performed to analyse the expression levels of TRPA1 and pyroptosis markers in vitro. Mitochondrial function was evaluated by flow cytometric analysis of the mitochondrial membrane potential (ΔΨm) and calcium influx. Simultaneously, intracellular and mitochondrial reactive oxygen species (ROS) levels were measured using fluorescence staining.
resultsTRPA1 was predominantly expressed in the fibroblast-rich zone and odontoblastic layer in the dental pulp, and its expression levels were positively correlated with pulp inflammation severity. In vitro, lipopolysaccharide (LPS) stimulation significantly increased the expression of pyroptosis-related markers and induced mitochondrial dysfunction, as evidenced by ΔΨm depolarization, intracellular Ca2+ overload, and excessive reactive oxygen species (ROS) generation. Notably, the pharmacological inhibition of the TRPA1 channel markedly attenuated these pathological changes, reducing pyroptosis-related markers responses and ameliorating mitochondrial impairment in human dental pulp cells (hDPCs).
conclusionDuring pulpitis, the expression of the TRPA1 channel was positively correlated with the severity of inflammation and pyroptosis-associated molecular signalling in dental pulp tissue. These findings suggest that TRPA1 may mediate mitochondrial damage through calcium ion influx, subsequently promoting cell pyroptosis in the context of pulpitis. These findings highlight a potential link between TRPA1 activation and mitochondrial dysfunction, warranting further investigation into the underlying mechanisms .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.